跳至主要内容
临床试验/CTRI/2023/03/050650
CTRI/2023/03/050650尚未招募Unknown

Effect of perioperative topical nepafenac 0.3% on central macular thickness after cataract surgery in patients with diabetes: A randomized controlled trial

pondicherry institute of medical sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • All diabetic patients in the age group 40yrs and above, will be undergoing routine cataract surgery.

排除标准

  • Preexisting macular diseases/ macular oedema
  • Recent intraocular surgery other than cataract surgery for 3 months
  • Intra operative complications during the surgery
  • Allergic or hypersensitive to NSAIDS, corticosteroids
  • Chronic and recurrent inflammatory eye diseases.
  • Use of any eye drops in last three months.
  • Diseases causing macular edema other than diabetes are age related macular degeneration, Retinal venous occlusion, Coats disease, Radiation retinopathy, choroidal tumors and retinitis pigmentosa Other drugs like chloroquine, tamoxifen and interferon can induce macular edema.

研究者

相似试验